Literature DB >> 18284106

Kentucky rural stimulant use: a comparison of methamphetamine and other stimulant users.

William W Stoops1, Michele Staton Tindall, Jennifer R Havens, Carrie B Oser, J Matthew Webster, Allison Mateyoke-Scrivner, Patricia B Wright, Brenda M Booth, Carl G Leukefeld.   

Abstract

Population based surveys suggest that methamphetamine use is increasing. However, little is known about stimulant use in rural areas. Given the lack of data regarding rural stimulant use, particularly methamphetamine use, and the continuing problems associated with stimulant drug use, the purpose of this study was to examine rural stimulant use in Kentucky. Of 225 rural stimulant-using participants surveyed, 76% (n = 170) reported lifetime use of methamphetamine. Rural methamphetamine users differed from other rural stimulant users on demographic characteristics, health, and drug use histories. These results suggest that differences exist between rural stimulant users and that clinicians may need to consider these differences when planning treatment and rehabilitation strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18284106     DOI: 10.1080/02791072.2007.10399902

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  3 in total

1.  Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine.

Authors:  William W Stoops; Erika Pike; Lon R Hays; Paul E Glaser; Craig R Rush
Journal:  Pharmacol Biochem Behav       Date:  2014-11-29       Impact factor: 3.533

2.  Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders.

Authors:  Adriane M Dela Cruz; Thomas Carmody; Tracy L Greer; Chad D Rethorst; Diane Warden; Robrina Walker; Madhukar H Trivedi
Journal:  Am J Addict       Date:  2016-03-15

3.  Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics.

Authors:  Jennifer R Havens; Hannah K Knudsen; Justin C Strickland; April M Young; Shanna Babalonis; Michelle R Lofwall; Sharon L Walsh
Journal:  Front Psychiatry       Date:  2022-01-07       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.